Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

NCT02097381 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Tenofovir-Emtricitabine plus Lopinavir/Ritonavir or Darunavir/Ritonavir

Sponsor

University of Roma La Sapienza

Collaborators

[object Object]